Pediatric Integrative Medicine in Academia: Stanford Children's Experience

Gautam Ramesh1, Dana Gerstbacher2, Jenna Arruda3

  • 1School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. gramesh@ucsd.edu.

Insights

Pediatric integrative medicine shows promise for treating common childhood conditions. This study outlines establishing an integrative medicine program in an academic center, highlighting evidence and success factors.

Area of Science:

  • Integrative Medicine
  • Pediatric Subspecialties
  • Academic Medical Centers

Background:

  • Pediatric integrative medicine is an emerging field with limited description in US academic medical centers.
  • Early research suggests promise for integrative modalities in treating common pediatric conditions like IBS, pain, headache, and allergies.
  • Increasing pediatric illness complexity necessitates a focus on holistic patient well-being.

Purpose of the Study:

  • To highlight evidence of effective integrative treatments in pediatric subspecialties.
  • To describe the establishment of a new pediatric integrative medicine program.
  • To summarize early program efforts and discuss barriers and success factors.

Main Methods:

  • Literature review of evidence for integrative treatments in pediatric subspecialties.
  • Description of the process for establishing a new pediatric integrative medicine program.
  • Summary of initial program activities and qualitative analysis of challenges and facilitators.

Main Results:

  • Evidence supports integrative medicine for conditions including irritable bowel syndrome, pain, headache, and allergies.
  • The establishment of the program involved interdisciplinary collaboration and resource allocation.
  • Early efforts focused on patient access and integration with existing pediatric services.

Conclusions:

  • Pediatric integrative medicine programs are feasible and beneficial in academic settings.
  • Successful implementation requires addressing potential barriers and identifying key success factors.
  • Further research is needed to fully elucidate the impact of integrative medicine on pediatric health outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...